These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37012965)

  • 1. Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma.
    Tunuguntla A; Suresh TN; Pn S
    Cureus; 2023 Mar; 15(3):e35686. PubMed ID: 37012965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 7. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stem cell biomarker CD44 in oral squamous cell carcinoma and its association with lymph node metastasis and TNM staging.
    Chakraborty S; Suresh TN; Azeem Mohiyuddin SM
    J Cancer Res Ther; 2024 Jul; 20(5):1430-1434. PubMed ID: 39412907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
    Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
    Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma.
    Zhu GJ; Song PP; Zhou H; Shen XH; Wang JG; Ma XF; Gu YJ; Liu DD; Feng AN; Qian XY; Gao X
    Oncol Lett; 2018 Mar; 15(3):3472-3481. PubMed ID: 29467869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
    Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
    Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of ADAM 12 Regulates Epithelial-mesenchymal Transition by Activating the Wnt/β-catenin Signaling Pathway in Colorectal Cancer.
    Huang C; Wang J; Xiang J; Wu C; Wang F; Chen J; Sun G; Xiang D
    Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38716545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.
    Gu GL; Zhu XQ; Wei XM; Ren L; Li DC; Wang SL
    World J Gastroenterol; 2014 Jan; 20(1):250-7. PubMed ID: 24415879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.
    Dai YC; Fang CY; Yang HY; Jian YJ; Wang SC; Liu YW
    PLoS One; 2021; 16(7):e0254000. PubMed ID: 34214117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
    Leng X; Huang G; Li S; Yao M; Ding J; Ma F
    PLoS One; 2021; 16(12):e0261138. PubMed ID: 34932597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
    Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
    Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.